(Approval lapsed) Yaltormin SR 500mg (metformin hydrochloride) Prolonged Release Tablets
Section 19A approved medicine
(Approval lapsed) Yaltormin SR 500mg (metformin hydrochloride) Prolonged Release Tablets
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
DIAFORMIN XR metformin hydrochloride 500mg extended release tablet blister pack - ARTG 120868
APO-METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 281211
APO-METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 281211
Indication(s)
Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Yaltormin SR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.